NCT02091219View on ClinicalTrials.gov

Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune Function

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

December 7, 2019

Conditions
Vitamin D Deficiency
Interventions
DRUG

Vitamin D

2400 IU/day by mouth for 16 weeks

DRUG

25(OH)D3

20 micrograms/day by mouth for 16 weeks

Trial Locations (2)

90095

UCLA Clinical and Translational Research Center (CTRC), Los Angeles

University of California, Los Angeles, Los Angeles

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of California, Los Angeles

OTHER

NCT02091219 - Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune Function | Biotech Hunter | Biotech Hunter